-
Something wrong with this record ?
HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer
J. Klozar, V. Kratochvil, M. Salakova, J. Smahelova, E. Vesela, E. Hamsikova, J. Betka, R. Tachezy
Language English Country Germany
Document type Research Support, Non-U.S. Gov't
Grant support
NR8126
MZ0
CEP Register
NR9466
MZ0
CEP Register
Digital library NLK
Full text - Část
Full text - Část
Source
Source
NLK
SpringerLink Journals
from 1997-01-01 to 2009-04-30
Medline Complete (EBSCOhost)
from 2000-01-01 to 1 year ago
- MeSH
- Alphapapillomavirus genetics isolation & purification MeSH
- Survival Analysis MeSH
- DNA, Viral chemistry MeSH
- Middle Aged MeSH
- Humans MeSH
- Human papillomavirus 16 genetics isolation & purification MeSH
- Lymphatic Metastasis MeSH
- Oropharyngeal Neoplasms mortality pathology virology MeSH
- Mouth Neoplasms mortality pathology virology MeSH
- Polymerase Chain Reaction MeSH
- Prognosis MeSH
- Risk Factors MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
- Geographicals
- Czech Republic MeSH
Prognostic factors are important for treatment decisions as they help adapt the therapy on a case-to-case basis. Nodal status, number of positive nodes, and presence of extracapsular spread are considered to be the important prognostic factors in head and neck cancer. Some studies suggest that human papillomavirus (HPV) status also influences the outcome of the treatment. This influence can be explained by the variation in tendency to develop regional metastases and by variation in the type of neck node involvement. The study objectives were to compare patients with HPV positive and HPV-negative tumors for survival and prevalence and type of regional metastasis, to identify prognostic factors and to test whether HPV presence is an independent factor of survival. The study included 81 patients treated by surgery including neck dissection for oral or oropharyngeal squamous cell cancer. A computerized medical report was completed for each patient. Analysis of the tumor specimen for the HPV DNA presence was done on paraffin-fixed tissue. HPV DNA detection and typing were performed by PCR with GP5+/GP6+BIO primers and reverse line blot hybridization. Overall, 64% (52/81) of tumors were HPV positive with 80% in the tonsillar site. HPV-positive patients had significantly better both overall (73 vs. 35%) (P=0.0112) and disease-specific (79 vs. 45%) (P=0.0015) survival rates than HPV-negative patients. No significant differences were found in the pN classification, in the number of positive nodes and the presence of extracapsular spread in the involved nodes between HPV positive and HPV-negative tumors. Multivariate analysis showed that significant prognostic factors of survival were the presence of HPV in the tumor, extracapsular spread and tumor size. HPV was the most significant prognostic factor in the studied group of patients with oropharyngeal tumors (HR=0.27, 95%CI 0.12-0.61) and possibly should be considered in treatment decisions.
References provided by Crossref.org
- 000
- 04075naa 2200541 a 4500
- 001
- bmc11006417
- 003
- CZ-PrNML
- 005
- 20140318142644.0
- 008
- 110401s2008 gw e eng||
- 009
- AR
- 024 __
- $a 10.1007/s00405-007-0557-9 $2 doi
- 035 __
- $a (PubMed)18094985
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Klozar, Jan, $d 1953- $7 nlk20050170309
- 245 10
- $a HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer / $c J. Klozar, V. Kratochvil, M. Salakova, J. Smahelova, E. Vesela, E. Hamsikova, J. Betka, R. Tachezy
- 314 __
- $a Department of Otolaryngology Head and Neck Surgery, 1st Faculty of Medicine, Charles University, Prague, Czech Republic.
- 520 9_
- $a Prognostic factors are important for treatment decisions as they help adapt the therapy on a case-to-case basis. Nodal status, number of positive nodes, and presence of extracapsular spread are considered to be the important prognostic factors in head and neck cancer. Some studies suggest that human papillomavirus (HPV) status also influences the outcome of the treatment. This influence can be explained by the variation in tendency to develop regional metastases and by variation in the type of neck node involvement. The study objectives were to compare patients with HPV positive and HPV-negative tumors for survival and prevalence and type of regional metastasis, to identify prognostic factors and to test whether HPV presence is an independent factor of survival. The study included 81 patients treated by surgery including neck dissection for oral or oropharyngeal squamous cell cancer. A computerized medical report was completed for each patient. Analysis of the tumor specimen for the HPV DNA presence was done on paraffin-fixed tissue. HPV DNA detection and typing were performed by PCR with GP5+/GP6+BIO primers and reverse line blot hybridization. Overall, 64% (52/81) of tumors were HPV positive with 80% in the tonsillar site. HPV-positive patients had significantly better both overall (73 vs. 35%) (P=0.0112) and disease-specific (79 vs. 45%) (P=0.0015) survival rates than HPV-negative patients. No significant differences were found in the pN classification, in the number of positive nodes and the presence of extracapsular spread in the involved nodes between HPV positive and HPV-negative tumors. Multivariate analysis showed that significant prognostic factors of survival were the presence of HPV in the tumor, extracapsular spread and tumor size. HPV was the most significant prognostic factor in the studied group of patients with oropharyngeal tumors (HR=0.27, 95%CI 0.12-0.61) and possibly should be considered in treatment decisions.
- 590 __
- $a bohemika - dle Pubmed
- 650 _2
- $a Alphapapillomavirus $x genetika $x izolace a purifikace $7 D052685
- 650 _2
- $a DNA virů $x chemie $7 D004279
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidský papilomavirus 16 $x genetika $x izolace a purifikace $7 D052162
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a lymfatické metastázy $7 D008207
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a nádory úst $x mortalita $x patologie $x virologie $7 D009062
- 650 _2
- $a nádory orofaryngu $x mortalita $x patologie $x virologie $7 D009959
- 650 _2
- $a polymerázová řetězová reakce $7 D016133
- 650 _2
- $a prognóza $7 D011379
- 650 _2
- $a rizikové faktory $7 D012307
- 650 _2
- $a analýza přežití $7 D016019
- 651 _2
- $a Česká republika $x epidemiologie $7 D018153
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Kratochvíl, Vít, $d 1980- $7 xx0071629
- 700 1_
- $a Saláková, Martina $7 xx0086174
- 700 1_
- $a Šmahelová, Jana $7 xx0110565
- 700 1#
- $a Veselá, Eva. $7 _AN039473
- 700 1_
- $a Hamšíková, Eva $7 xx0052821
- 700 1_
- $a Betka, Jan, $d 1949- $7 jn20000400169
- 700 1_
- $a Tachezy, Ruth $7 xx0060363
- 773 0_
- $t European Archives of Oto-Rhino-Laryngology $w MED00009617 $g Roč. 265,Suppl 1 (2008), s. S75-S82 $x 0937-4477
- 910 __
- $a ABA008 $b x $y 2 $z 0
- 990 __
- $a 20110414104033 $b ABA008
- 991 __
- $a 20140318142709 $b ABA008
- 999 __
- $a ok $b bmc $g 834009 $s 698518
- BAS __
- $a 3
- BMC __
- $a 2008 $x MED00009617 $b 265 $c Suppl 1 $d S75-S82 $i 0937-4477 $m European archives of oto-rhino-laryngology $n Eur Arch Otorhinolaryngol
- GRA __
- $a NR8126 $p MZ0
- GRA __
- $a NR9466 $p MZ0
- LZP __
- $a 2011-1B09/jjme